TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells
Cancer Gene Therapy, 07/11/2012
Moniri MR et al. – The results suggest that Mesenchymal stem cells (MSCs) exhibit intrinsic inhibition of pancreatic cancer cells and that this effect can be potentiated by tumor necrosis factor–related apoptosis–inducing ligand (TRAIL)–transfection on death receptor–bearing cell types.



